0002153574-26-000001.txt : 20260909 0002153574-26-000001.hdr.sgml : 20260909 20260908193037 ACCESSION NUMBER: 0002153574-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260909 DATE AS OF CHANGE: 20260908 EFFECTIVENESS DATE: 20260909 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cloverleaf Bio, Inc. CENTRAL INDEX KEY: 0002153574 ORGANIZATION NAME: EIN: 931966483 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-596761 FILM NUMBER: 261366278 BUSINESS ADDRESS: STREET 1: 101 COLLEGE STREET, #210 CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 347-596-9754 MAIL ADDRESS: STREET 1: 101 COLLEGE STREET, #210 CITY: NEW HAVEN STATE: CT ZIP: 06510 D 1 primary_doc.xml X0708 D LIVE 0002153574 Cloverleaf Bio, Inc. 101 COLLEGE STREET, #210 NEW HAVEN CT CONNECTICUT 06510 347-596-9754 DELAWARE None None Corporation true 2023 Austin Draycott 101 College Street, #210 New Haven CT CONNECTICUT 06510 Executive Officer Director Cole Lewis 101 College Street, #210 New Haven CT CONNECTICUT 06510 Executive Officer Dima Kuzmin 101 College Street, #210 New Haven CT CONNECTICUT 06510 Director Christina Vorvis 101 College Street, #210 New Haven CT CONNECTICUT 06510 Director Matthias Samwer 101 College Street, #210 New Haven CT CONNECTICUT 06510 Director Biotechnology Decline to Disclose 06b false 2026-08-24 false true false 0 29599977 14799988 14799989 false 12 0 0 0 Proceeds are available to fund general working capital requirements; no proceeds have been or are proposed to be used for payments to directors, executive officers, or promoters based specifically on the closing of this financing. false Cloverleaf Bio, Inc. /s/ Austin Draycott Austin Draycott President 2026-09-04